ClearPoint Neuro Inc. (CLPT)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $454.34M
- P/E ratio
- —
- EPS
- —
- Volume
- 570,546
- 52-week high
- —
- 52-week low
- —
- Open
- $15.30
- Day high
- $15.52
- Day low
- $14.80
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $36.97M | -$25.54M | -$0.90 |
| 2024 | $31.39M | -$18.91M | -$0.70 |
| 2023 | $23.96M | -$22.09M | -$0.90 |
| 2022 | $20.55M | -$16.44M | -$0.68 |
| 2021 | $16.3M | -$14.41M | -$0.69 |
About ClearPoint Neuro Inc.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
- CEO
- Joseph Michael Burnett
- Employees
- 172
- Country
- US
- IPO date
- May 22, 2012
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is ClearPoint Neuro Inc.'s stock price today?
- CLPT is trading at $15.05 as of Jul 20, 2026.
- What is ClearPoint Neuro Inc.'s market cap?
- ClearPoint Neuro Inc. (CLPT) has a market capitalization of $454.34M.
- Does ClearPoint Neuro Inc. pay a dividend?
- ClearPoint Neuro Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is ClearPoint Neuro Inc. in?
- ClearPoint Neuro Inc. operates in the Healthcare sector.